Abstract
Immune-mediated stem cell damage has been postulated to be responsible for disease initiation and progression in aplastic anemia (AA). It is hypothesized that T lymphocytes play a major role in destroying the bone marrow (BM) stem cells of AA patients by infiltrating the BM and secreting excessive levels of anti-hematopoietic cytokines, interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α). We undertook this study to assess the pathogenic significance of anti-hematopoietic cytokines such as IFN-γ and TNF-α in BM T cells and plasma of AA patients. Significantly elevated levels of IFN-γ and TNF-α were found in the BM plasma of AA patients compared to controls (p=0.05 and 0.006, respectively). Intracellular IFN-γ and not TNF-α in BM CD3+ T cells of AA patients was significantly higher compared to controls (p=0.04 and p=0.2, respectively). A follow-up analysis of expression of these cytokines in BM T cells and their levels in BM plasma in five AA patients before and 180 days (6 months) after antithymocyte globulin (ATG) and cyclosporin A (CsA) therapy showed a decline 180 days after therapy compared to pre-therapy. We thus conclude that increased production of both IFN-γ and TNF-α in the BM may contribute to disease pathogenesis in AA and ATG therapy may induce hematological remission by suppressing the elevated levels of IFN-γ and TNF-α in AA BM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bacigalupo A, How J, Gluckman E, Nissen C, Marsh J, Van Lint MT (1988) Bone marrow transplantation (BMT) versus immunosuppression for treatment of severe aplastic anaemia (SAA): a report of EBMT SAA working party. Br J Haematol 70:177–182
Camitta BM, Rappenport JM, Parkmann R, Nathan DG (1975) Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood 45:355–363
Dubey S, Srivastava A, Nityanand S (2002) Induction of apoptosis of peripheral blood mononuclear cells by antithymocyte globulin (ATG) in aplastic anemia: an in vivo and in vitro study. Ann Hematol 81:249–253
Dufour C, Corcione A, Svahn J, Haupt R, Battillana N, Pistola V (2001) Interferon-γ and tumour necrosis factor-α are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia. Br J Haematol 115:1023–1031
Frickhoven N, Rosenfeld SJ (2000) Immunosuppressive treatment of aplastic anemia with antilymphocyte globulin and cyclosporine. Semin Hematol 37:56–68
Hinterberger W, Gunther A, Gerald A, Dudczak R, Geibler K, Hocker P, Huber C, Kalhs P, Knapp W, Koller U, Lechner K, Platzer B (1988) Further evidence for lymphokine overproduction in aplastic anemia. Blood 72:266–272
Martinez-Jaramillo MG, Figueroa EF, Morales GG, Valle ES, Mayani H (2001) Tumor necrosis factor-alpha levels in long-term marrow cultures from patients with aplastic anemia: modulation by granulocyte–macrophage colony-stimulating factor. Am J Hematol 68:144–148
Jung T, Schauer U, Heusser C, Neumann C, Rieger C (1993) Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159:197–207
Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS (1995) Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anemia. Br J Haematol 91:245–252
Maciejewski JP, Anderson S, Katevas P, Young NS (1994) Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 87:227–234
Melenhorst JJ, Van Krieken J, Dreef E, Landegent JE, Willemze R, Fibbe WE (1997) T cell selectively infiltrates bone marrow areas with residual hematopoiesis of patients with acquired anemia. Br J Haematol 99:517–519
Risitano AM, Kook H, Zeng W, Chen G, Young NS, Maciejewski JP (2002) Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry. Blood 100:178–183
Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS (2004) In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 364:355–364
Schultz JC, Shahidi NS (1994) Detection of tumor necrosis factor-α in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. Am J Hematol 45:32–38
Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP (1995) Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 165:538–546
Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS (2002) Intracellular interferon-γ in circulating and marrow T cells detected by flow cytometry and response to immunosuppressive therapy in patients with aplastic anemia. Blood 100:1185–1191
Young NS (2002) Acquired aplastic anemia. Ann Med 136:534–546
Young NS, Barret JA (1995) The treatment of severe acquired aplastic anemia. Blood 85:3367–3377
Young NS (2000) Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Semin Hematol 37:3–14
Zeng W, Nakao S, Takamatsu H, Yachie A, Takami A, Kondo Y, Sugimori N, Yamazaki H, Miura Y, Shiobara S, Matsuda T (1999) Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia. Blood 93:3008–3016
Zoumbos NC, Gascon P, Djeu J, Trost SR, Young NS (1985) Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312:257–264
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dubey, S., Shukla, P. & Nityanand, S. Expression of interferon-γ and tumor necrosis factor-α in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Ann Hematol 84, 572–577 (2005). https://doi.org/10.1007/s00277-005-1022-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-005-1022-8